ACER insider filings
Acer Therapeutics Inc. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-11-20. Screen ACER transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ACER between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Acer Therapeutics Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-11-20 | 4 | ASELAGE STEVE — Director | Disposition to issuer (D): 483,741 | EDGAR |
| 2023-11-20 | 4 | DUNN JOHN MICHAEL — Director | Disposition to issuer (D): 27,380 | EDGAR |
| 2023-11-20 | 4 | Joseph Donald — See Remarks | Disposition to issuer (D): 14,285 | EDGAR |
| 2023-11-20 | 4 | Schelling Chris — PRESIDENT AND CEO, Director, 10% owner | Disposition to issuer (D): 2,712,529 | EDGAR |
| 2023-11-20 | 4 | PALMIN HARRY S — CHIEF FINANCIAL OFFICER | Disposition to issuer (D): 125,000 | EDGAR |
| 2023-11-20 | 4 | Davis Jefferson E — CHIEF BUSINESS OFFICER | Disposition to issuer (D): 71,645 | EDGAR |
| 2023-03-16 | 4 | Quartel Adrian W — Chief Medical Officer | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Paul Bernard H — Chief People Officer | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | PALMIN HARRY S — Chief Financial Officer | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Klopp John Michael — Chief Technical Officer | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Joseph Donald — Chief Legal Officer and Secy | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Hayden Tanya — Chief Operating Officer | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | GRIFFIN MICHELLE RENEE — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | DUNN JOHN MICHAEL — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Davis Jefferson E — Chief Business Officer | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | ASELAGE STEVE — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Amello Jason — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Acer Therapeutics Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-11-20 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2023-11-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-07 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-05-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-04 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ACER returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →